Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 475-300-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From May, 16 2006 to May 30, 2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1200 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- -
- EC Number:
- 475-300-1
- EC Name:
- -
- Cas Number:
- 910030-59-0
- Molecular formula:
- Hill formula: C29H25N8Na5O22S7 CAS formula: C29H30N8O22S7.5Na
- IUPAC Name:
- Pentasodium 2,2'-((2,4-diamino-5-(4-methoxy-2-sulfophenylazo )-1,3-phenylene)bis(azo))bis(5-(2-(sulfonatooxyethyl)sulfony l)benzenesulfonate
- Test material form:
- solid: particulate/powder
- Details on test material:
- see below
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- CRL:(WI) BR Wistar rats
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (Europe) laboratories INC.
- Hygienic level at arrival: SPF
- Age at study initiation: Young adult rats
- Body weight range at treatment: Male: 243 - 271 g; Female: 236 - 245 g
- Sex: Male and female; female rats were nulliparous and non-pregnant
- Housing: Type II polypropylene/polycarbonate, individual caging
- Bedding: Laboratory bedding
- Diet: Ssniff RIM-Z+H complete diet, ad libitum
- Water: Tap water from 500 mL bottle, ad libitum
- Acclimation period: Female: 20 d; male: 6 d
-Animal identification: Numbers on the tail written with a permanent marker; The cages were marked by identity cards with information about study code, sex, dose group, cage number and individual animal number
ENVIRONMENTAL CONDITIONS
- Temperature: 22±3°C
- Humidity: 30 - 70%
- Air changes: 8-12 air exchanges/hour by central air-condition system
- Photoperiod: 12 h light/dark cycle
IN-LIFE DATES: From: To: May, 16 2006 to May 30, 2006
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
The back of animals was shaven (approximately 10% area of the total body surface) 24 h prior to the treatment. The test substance was applied in a single dose in original form uniformly over the shaved skin throughout a 24 h exposure period. Sterile gauze pads were placed on the skin of rats. These gauzes were kept in contact with the skin by a patch with adhesive hypoallergenic plaster. The entire trunk of the animal was wrapped with semi occlusive plastic wrap for 24 h.
REMOVAL OF TEST SUBSTANCE
At the end of the exposure period, residual test item was removed, using body temperature water.
PREPARATION OF THE TEST SUBSTANCE
For the treatment the test substance was applied in original form moistened with 0.5 mL of distilled water. - Duration of exposure:
- 24 h
- Doses:
- 2,000 mg/kg bw
- No. of animals per sex per dose:
- Five/sex/dose
- Control animals:
- not required
- Details on study design:
- Experimental design
Dose Group Number of animals
Male Group (2,000 mg/kg bw) 5
Female Group (2,000 mg/kg bw ) 5
A single administration was performed by dermal route and was followed by a 14 d observation period.
OBSERVATIONS
Clinical Observations
Careful clinical observation was made at the following intervals: 1h, 5h after the treatment and once each day for 14 d thereafter. Individual observations included the skin and fur, eyes and mucous membranes, and also respiratory, circulatory, autonomic and central nervous system, somatomotor activity and behaviour pattern as well. Particular attention was directed to the observation of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.
Body Weight Measurement
The body weight of each animal was recorded on Day 0 (shortly before the treatment), then on Days 7 and 14 with a precision of 1 g.
NECROPSY
At the end of the observation period gross pathology was conducted in every experimental animal. Animals were exsanguinated under pentobarbital anaesthesia. After examination of the external appearance, the cranial, thoracic, and abdominal cavities were opened and tissues, organs were observed. Gross pathological changes were recorded for each animal on the post mortem record sheets.
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- No mortality occurred after the 24 h dermal exposure to test substance in CRL(WI)BR rats.
- Clinical signs:
- other: No behavioural changes or general toxic symptoms were noted during the study. The skin remained brownish coloured after careful washing off of test substance, thus it was not feasible to evaluate erythema. In three cases (1/5 male, 2/5 female) some small
- Gross pathology:
- Test substance related macroscopic alterations were not found at the gross pathology. Pinprick-sized haemorrhages (5/5 male, 2/5 female) were observed in the lungs, which were caused by exsanguination procedures. Hydrometra (1/5) due to the sexual cycle is a common alteration in experimental rats.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the study conditions, the dermal LD50 of the test substance was found to be >2,000 mg/kg bw in rats.
- Executive summary:
A study was conducted to assess the acute dermal toxicity of the test substance in CRL:(WI) BR Wistar rats according to OECD Guideline 402, EU Method B.3. and EPA OPPTS 870.1200, in compliance with GLP.
Groups of five female and five male rats received a single dermal dose of 2,000 mg/kg bw. Test substance moistened with 0.5 mL of distilled water was applied topically under semi-occlusive conditions for 24 h.
No mortality occurred, no clinical symptoms were observed and no significant macroscopic abnormalities were seen at necropsy. Body weight was also not impaired. Although, the skin of the animals was brownish coloured by the test substance and some small wounds were observed on the treated skin surface in three animals, skin recovered between Days 4 and 6.
Under the study conditions, the dermal LD50 of the test substance was found to be >2,000 mg/kg bw in rats
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
